Cyclosporine and graft coronary artery disease after heart transplantation.
Risk factors for graft coronary artery disease after heart transplant are discussed in relationship to cyclosporine dosages. Patients receiving a mean cyclosporine dose higher than 4 mg/kg/day had lower incidence of graft coronary disease than patients receiving lower dosages.
Gamba
A
A
Department of Cardiac Surgery, Ospedali Riuniti di Bergamo, Italy.
Mammana
C
C
Fiocchi
R
R
Iamele
L
L
Mamprin
F
F
D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D012307:Risk Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine